Loading...
XSAU
4009
Market cap1.53bUSD
May 19, Last price  
62.40SAR
1D
-0.48%
1Q
-23.53%
Jan 2017
-14.81%
IPO
-19.22%
Name

Middle East Healthcare Company SJSC

Chart & Performance

D1W1MN
XSAU:4009 chart
P/E
20.37
P/S
1.99
EPS
3.06
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
14.01%
Revenues
2.88b
+8.66%
542,221,996828,359,8601,398,751,6121,534,527,9761,615,641,1541,629,429,6071,390,690,3931,496,646,9131,772,209,6161,872,620,7902,151,743,7362,653,170,4752,882,818,291
Net income
282m
+56.51%
61,994,012137,197,859331,969,205390,249,302361,860,047300,082,828172,249,37197,568,34781,992,57211,732,48675,182,816180,176,414282,001,652
CFO
766m
+300.87%
-2,430,724128,505,012349,281,631193,996,071257,303,609340,637,928161,355,86098,638,314-263,389,19376,621,68576,023,275191,083,162766,001,422
Dividend
Jun 25, 20182 SAR/sh
Earnings
Aug 04, 2025

Profile

Middle East Healthcare Company, a healthcare provider, owns and operates a network of hospitals under the Saudi German Hospital name in the Middle East and North Africa. The company operates multi-specialty tertiary level hospitals, which comprise Saudi German Hospital–Jeddah with 218 beds; Saudi German Hospital-Aseer with 400 beds; Saudi German Hospital-Riyadh with 300 beds; Saudi German Hospital-Madinah with 300 beds; and Saudi German Hospital-Hail with 150 beds. Its multi-specialty tertiary care hospitals also include Saudi German Hospital-Dammam with 150 to 300 beds; Saudi German Hospital-Sanaa with 300 beds; Saudi German Hospital–Dubai with 300 beds; Saudi German Hospital–Sharjah with 50 beds; Saudi German Hospital–Ajman with 100-200 beds; and Saudi German Hospital-Cairo with 332 beds. The company was founded in 1988 and is based in Jeddah, the Kingdom of Saudi Arabia.
URL
IPO date
Mar 29, 2016
Employees
Domiciled in
SA
Incorporated in
SA

Valuation

Title
SAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,882,818
8.66%
2,653,170
23.30%
2,151,744
14.91%
Cost of revenue
1,986,876
2,310,672
1,586,086
Unusual Expense (Income)
NOPBT
895,942
342,498
565,658
NOPBT Margin
31.08%
12.91%
26.29%
Operating Taxes
26,277
17,983
9,616
Tax Rate
2.93%
5.25%
1.70%
NOPAT
869,665
324,515
556,042
Net income
282,002
56.51%
180,176
139.65%
75,183
540.81%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
652,402
1,129,192
1,002,887
Long-term debt
1,896,571
1,414,674
1,306,410
Deferred revenue
8,137
9,393
10,724
Other long-term liabilities
367,766
240,185
211,996
Net debt
2,496,691
2,499,443
2,293,696
Cash flow
Cash from operating activities
766,001
191,083
76,023
CAPEX
(470,824)
(229,612)
(249,527)
Cash from investing activities
(508,824)
(241,989)
(249,396)
Cash from financing activities
(256,071)
79,726
160,845
FCF
724,715
(131,549)
229,211
Balance
Cash
52,282
44,423
15,602
Long term investments
Excess cash
Stockholders' equity
1,446,540
1,564,762
1,408,160
Invested Capital
4,515,815
4,299,574
3,848,690
ROIC
19.73%
7.97%
15.10%
ROCE
19.84%
7.97%
14.70%
EV
Common stock shares outstanding
92,040
92,040
92,040
Price
68.70
-22.20%
88.30
246.95%
25.45
-19.59%
Market cap
6,323,148
-22.20%
8,127,132
246.95%
2,342,418
-19.59%
EV
8,867,790
10,672,258
4,679,313
EBITDA
1,112,690
532,311
711,632
EV/EBITDA
7.97
20.05
6.58
Interest
220,588
159,807
65,986
Interest/NOPBT
24.62%
46.66%
11.67%